Coming News ???, page-285

Took a look at this, MATH+1 appears to be less effective in mechanical ventilator dependent patients, with a survival rate of 33% in one study (1.). This contrasts to our trials where the eligibility criteria is patients "requiring mechanical ventilatory support".

The crucial factor with the MATH+1 protocol and its effectiveness is the timing of its application - needs to applied early to demonstrate higher success according to sources online. I think there's yet to be any reports with sufficient data demonstrating how effective this protocol has been (and under what criteria/circumstances), we shall see.

Remestemcel-L has shown positive results in the worst scenarios (and the interim readout hopefully confirms this), so I'd say we're in the green.